Thursday, July 28, 2016

New Therapeutic Target for Lung Cancer Driven by KRAS

… underlying biology of KRAS in lung cancer determined that activity resulting from … these lung cancer cells to survive, and that suppressing ACSL3causes these lung cancer cells … also the survival of established lung cancer. Since we have no clinically-relevant …

No comments:

Post a Comment